SAN DIEGO, June 14, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that the San Diego pharmaceutical company, which specializes in products utilizing its proprietary NexACT® technology, will be added to the Russell Microcap® Index when Russell Investments reconstitutes its family of U.S. indexes on June 24th, according to a preliminary list of additions posted June 10th on www.russell.com/indexes.
